Pharmacology

Articles:

194 Chemical synthesis yields gram quantities of a scarce compound under study for treating HIV, cancer, and Alzheimer’s disease.
http://science.sciencemag.org/content/358/6360/218

193 Ceftazidime-avibactam has potent sterilizing activity against highly drug-resistant tuberculosis.
http://advances.sciencemag.org/content/3/8/e1701102

192 Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents.
https://www.nature.com/articles/s41467-017-00419-5

191 Plasmonic silver nanoshells for drug and metabolite detection.
https://www.nature.com/articles/s41467-017-00220-4

190 Synergy of synthesis, computation and NMR reveals correct baulamycin structures.
http://www.nature.com/nature/journal/v547/n7664/full/nature23265.html

189 Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13.
http://www.cell.com/cell/fulltext/S0092-8674(17)30709-2

188 A novel humanized mouse lacking murine P450 oxidoreductase for studying human drug metabolism.
https://www.nature.com/articles/s41467-017-00049-x

187 Click chemistry enables preclinical evaluation of targeted epigenetic therapies.
http://science.sciencemag.org/content/356/6345/1397

186 Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment.
http://www.nature.com/nm/journal/v23/n6/abs/nm.4324.html

185 A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis.
https://www.nature.com/nature/journal/v546/n7658/full/nature22337.html

184 Predictive compound accumulation rules yield a broad-spectrum antibiotic.
https://www.nature.com/nature/journal/v545/n7654/full/nature22308.html

183 Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab.
http://www.nejm.org/doi/full/10.1056/NEJMoa1614062

182 Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a.
http://www.pnas.org/content/114/14/3750.abstract

181 The druggable genome and support for target identification and validation in drug development.
http://stm.sciencemag.org/content/9/383/eaag1166

180 Systemic delivery of factor IX messenger RNA for protein replacement therapy.
http://www.pnas.org/content/114/10/E1941.abstract

179 CD6 as a potential target for treating multiple sclerosis.
http://www.pnas.org/content/114/10/2687.abstract

178 A nontoxic pain killer designed by modeling of pathological receptor conformations.
http://science.sciencemag.org/content/355/6328/966

177 Pharmacologic inhibition of Hsp90 to prevent GLT-1 degradation as an effective therapy for epilepsy.
http://jem.rupress.org/content/214/2/547

176 Allosteric “beta-blocker” isolated from a DNA-encoded small molecule library.
http://www.pnas.org/content/114/7/1708.abstract

175 Drug discovery for Diamond-Blackfan anemia using reprogrammed hematopoietic progenitors.
http://stm.sciencemag.org/content/9/376/eaah5645

Free Images for Presentation: sunipix SUNIPIX